Dangerous Combination
Combining Nifoxipam and Baclofen is classified as dangerous. Combined CNS depression; risk of respiratory failure
Nifoxipam, a Depressant, and Baclofen, a Depressant, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Both are classified as Depressants, meaning they share a common pharmacological foundation. They share 11 documented effects in common, with 13 effects unique to Nifoxipam and 13 unique to Baclofen. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Effects |
| 24 documented |
| 24 documented |
| Interaction | Dangerous | |
| Level | Nifoxipam | Baclofen |
|---|---|---|
| Threshold | 0.1 mg | 5 mg |
| Light | 0.25–0.5 mg | 10–20 mg |
| Common | 0.5–1 mg | 20–50 mg |
| Strong | 1–2 mg | 50–100 mg |
| Heavy | 2 mg | 100 mg |
Nifoxipam
Baclofen
Combined CNS depression; risk of respiratory failure